Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Category: Workers Comp

499 posts found
Imagery of an injectable product

FDA Declares Semaglutide Shortage Over

The GLP-1 receptor agonist has been considered in shortage since 2022, but the FDA confirmed with manufacturers that presented and projected demand can now be met.
Read More

4 Ways PBMs Can Improve the Workers’ Comp Experience

PBMs can reduce burden for payers, provide intuitive claims tools, provide effective customer support, and engage injured workers.
Read More
Image of Healthcare worker looking stressed

PTSD Presumptions Continue to See Activity

New York backpedaled on a PTSD presumption for all workers, while California considers a PTSD presumption for healthcare workers.
Read More

WCRI Reports on the Pandemic’s Impact on Medical Utilization

Despite decreases in injury frequency across all groups, younger workers still saw higher use of emergency departments.
Read More
Therapy imagery

Psilocybin and Ketamine Therapy Bills Introduced Across the Country

So far, seven psilocybin therapy bills have been introduced in 2025, with three ketamine therapy bills.
Read More
Image of Mike Theis

Healthesystems Announces Key Promotion to Support Innovation in Data Analytics

Mike Theis has been promoted to AVP, Product Analytics and Business Strategy
Read More
image of pills

FDA Approves Novel Non-Opioid Journavx for Moderate to Severe Pain

A first-in-class medication, Journavx targets pain-signaling pathways involving sodium channels.
Read More
article image

2025 Workers’ Comp Industry Insights Survey Report

The seventh annual survey report highlights the top challenges and priorities for 515 industry stakeholders.
Read More
article image

Flurry of States Eye Updates for Cancer and PTSD Presumptions

Various states are proposing modifications to existing presumptions to expand coverage for first responders.
Read More
lab image

Cebranopadol Phase 3 Trials Show Promising Results

A compound opioid/NOP receptor agonist demonstrated pain relief with a safety profile comparable to placebo.
Read More

WCRI Reports on Changes in the Medical Workforce and the Impact on Claims

Pandemic driven increases to provider vacancies have increased reliance on nurse practitioners and physician assistants.
Read More
article image

A Hot Topic: The Latest News on Workers and Extreme Heat

Recent data insights, state proposals, and updates on federal rulemaking procedures.
Read More

FDA Approves Generic GLP-1 Victoza Injections for Type 2 Diabetes

Victoza® (liraglutide) injections are a GLP-1 receptor agonist, a drug class experiencing shortages due to their high demand.
Read More

From A-to-Z: 5 Population Considerations for Gen Z

Health trends to consider in this growing portion of the workforce.
Read More

FDA Issues Draft Guidance for the Use of AI in the Creation of Drugs and Medical Devices

The guidelines provide recommendations on using AI to demonstrate drug safety and effectiveness, and recommendations for AI-enabled medical devices.
Read More
1 2 3 4 5 30 31 32 33 34
lockmap-markermagnifiercrossmenuarrow-rightcross-circle